Kanada -
anglų -
Health Canada
apo-pomalidomide capsule
apotex inc - pomalidomide - capsule - 2mg - pomalidomide 2mg
Kanada -
anglų -
Health Canada
apo-pomalidomide capsule
apotex inc - pomalidomide - capsule - 4mg - pomalidomide 4mg
Kanada -
anglų -
Health Canada
reddy-pomalidomide capsule
dr reddy's laboratories ltd - pomalidomide - capsule - 1mg - pomalidomide 1mg
Kanada -
anglų -
Health Canada
reddy-pomalidomide capsule
dr reddy's laboratories ltd - pomalidomide - capsule - 2mg - pomalidomide 2mg
Kanada -
anglų -
Health Canada
reddy-pomalidomide capsule
dr reddy's laboratories ltd - pomalidomide - capsule - 4mg - pomalidomide 4mg
Izraelis -
anglų -
Ministry of Health
imnovid 3 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 3 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide.
Izraelis -
anglų -
Ministry of Health
imnovid 3 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 3 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide
Izraelis -
anglų -
Ministry of Health
imnovid 3 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 3 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide
Izraelis -
anglų -
Ministry of Health
imnovid 3 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 3 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide
Izraelis -
anglų -
Ministry of Health
imnovid 3 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 3 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide